Literature DB >> 21234721

Second primary tumors in patients with head and neck cancer.

Antonio Vitor Martins Priante1, Emanuel Celice Castilho, Luiz Paulo Kowalski.   

Abstract

This is a review on second primary tumors in patients with head and neck cancer. These patients have a high risk of developing other cancers simultaneously or subsequently. The incidence of multiple primary tumors in this population can be as high as 27%. Recurrences are the most common cause of treatment failure within the first 2 years of follow-up. After the third year the diagnosis of a second primary tumor becomes the most important cause of morbimortality in head and neck cancer patients, especially in those treated for cancers early diagnosed. Most second primary tumors occur in the upper aerodigestive tract (40%-59%), lung (31%-37.5%), and esophagus (9%-44%). Patients who develop second primary tumor have a significant reduction of survival expectancy.

Entities:  

Mesh:

Year:  2011        PMID: 21234721     DOI: 10.1007/s11912-010-0147-7

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  48 in total

1.  Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

Authors:  W K Hong; S M Lippman; L M Itri; D D Karp; J S Lee; R M Byers; S P Schantz; A M Kramer; R Lotan; L J Peters
Journal:  N Engl J Med       Date:  1990-09-20       Impact factor: 91.245

2.  The role of panendoscopy in the management of mucosal head and neck malignancy-a prospective evaluation.

Authors:  J Davidson; R Gilbert; J Irish; I Witterick; D Brown; D Birt; J Freeman; P Gullane
Journal:  Head Neck       Date:  2000-08       Impact factor: 3.147

3.  Multiple synchronous and metachronous cancers of the upper aerodigestive tract: a nine-year study.

Authors:  E Panosetti; B Luboinski; G Mamelle; J M Richard
Journal:  Laryngoscope       Date:  1989-12       Impact factor: 3.325

4.  EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups.

Authors:  N van Zandwijk; O Dalesio; U Pastorino; N de Vries; H van Tinteren
Journal:  J Natl Cancer Inst       Date:  2000-06-21       Impact factor: 13.506

Review 5.  Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.

Authors:  J H Lee; M Machtay; M G McKenna; G S Weinstein; D A Markiewicz; R E Krisch; M M Kligerman
Journal:  Am J Otolaryngol       Date:  2001 Jan-Feb       Impact factor: 1.808

6.  Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck.

Authors:  Dapeng Lei; Erich M Sturgis; Zhensheng Liu; Mark E Zafereo; Qingyi Wei; Guojun Li
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

7.  Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan?

Authors:  Emmanuel Guardiola; Xavier Pivot; Olivier Dassonville; Gilles Poissonnet; Pierre-Yves Marcy; Josiane Otto; Michel Poudenx; Eric Francois; René-Jean Bensadoun; Antoine Thyss; François Demard; Maurice Schneider
Journal:  Cancer       Date:  2004-11-01       Impact factor: 6.860

8.  Is routine triple endoscopy cost-effective in head and neck cancer?

Authors:  A Shaha; E Hoover; J Marti; Y Krespi
Journal:  Am J Surg       Date:  1988-06       Impact factor: 2.565

9.  Panendoscopy and simultaneous primary tumours in patients presenting with early carcinoma of the mobile tongue.

Authors:  Cyrus J Kerawala; Brian Bisase; Jon Lee
Journal:  Br J Oral Maxillofac Surg       Date:  2008-12-31       Impact factor: 1.651

10.  Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study.

Authors:  Xavier León; María del Prado Venegas; César Orús; Montserrat López; Jacinto García; Miquel Quer
Journal:  Cancer Causes Control       Date:  2008-12-06       Impact factor: 2.506

View more
  19 in total

1.  Coordinated expression of cyclin-dependent kinase-4 and its regulators in human oral tumors.

Authors:  Ming J Poi; Thomas J Knobloch; Marta T Sears; Lana K Uhrig; Blake M Warner; Christopher M Weghorst; Junan Li
Journal:  Anticancer Res       Date:  2014-07       Impact factor: 2.480

Review 2.  AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma.

Authors:  Cory D Fulcher; Missak Haigentz; Thomas J Ow
Journal:  Head Neck       Date:  2017-11-24       Impact factor: 3.147

3.  Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer.

Authors:  S Partovi; A Kohan; J L Vercher-Conejero; C Rubbert; S Margevicius; M D Schluchter; C Gaeta; P Faulhaber; M R Robbin
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-12       Impact factor: 3.825

Review 4.  Ion Channel Dysregulation in Head and Neck Cancers: Perspectives for Clinical Application.

Authors:  Nagore Del-Río-Ibisate; Rocío Granda-Díaz; Juan P Rodrigo; Sofía T Menéndez; Juana M García-Pedrero
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

5.  Pattern of Recurrence After Platinum-Containing Definitive Therapy and Efficacy of Salvage Treatment for Recurrence in Patients with Squamous Cell Carcinoma of the Head and Neck.

Authors:  Tetsuro Wakasugi; Thi Nga Nguyen; Shoko Takeuchi; Jun-Ichi Ohkubo; Hideaki Suzuki
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

6.  Molecular etiology of second primary tumors in contralateral tonsils of human papillomavirus-associated index tonsillar carcinomas.

Authors:  Andrew W Joseph; Takenori Ogawa; Justin A Bishop; Sofia Lyford-Pike; Xiaofei Chang; Timothy H Phelps; William H Westra; Sara I Pai
Journal:  Oral Oncol       Date:  2012-10-10       Impact factor: 5.337

7.  Endoscopic near-infrared photoimmunotherapy in an orthotopic head and neck cancer model.

Authors:  Ryuhei Okada; Aki Furusawa; Fuyuki Inagaki; Hiroaki Wakiyama; Takuya Kato; Shuhei Okuyama; Hideyuki Furumoto; Hiroshi Fukushima; Peter L Choyke; Hisataka Kobayashi
Journal:  Cancer Sci       Date:  2021-06-23       Impact factor: 6.518

8.  Value of probe-based confocal laser endomicroscopy (pCLE) and dual focus narrow-band imaging (dNBI) in diagnosing early squamous cell neoplasms in esophageal Lugol's voiding lesions.

Authors:  Piyapan Prueksapanich; Rapat Pittayanon; Rungsun Rerknimitr; Naruemon Wisedopas; Pinit Kullavanijaya
Journal:  Endosc Int Open       Date:  2015-04-13

9.  TIMP3 and CCNA1 hypermethylation in HNSCC is associated with an increased incidence of second primary tumors.

Authors:  Marianna Marconato Rettori; Ana Carolina de Carvalho; Ana Luiza Bomfim Longo; Cleyton Zanardo de Oliveira; Luiz Paulo Kowalski; André Lopes Carvalho; André Luiz Vettore
Journal:  J Transl Med       Date:  2013-12-20       Impact factor: 5.531

10.  Suppression of MAGE-A10 alters the metastatic phenotype of tongue squamous cell carcinoma cells.

Authors:  Bruna Dos Santos Mendonça; Michelle Agostini; Iara Gonçalves Aquino; Wagner Barbosa Dias; Débora Campanella Bastos; Franklin D Rumjanek
Journal:  Biochem Biophys Rep       Date:  2017-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.